Latest News
-

Huntington's disease goes viral as UniQure inches ahead in gene therapy race
⏱️ 9 min read
FDA grants “Investigational New Drug” status to Huntingtin-lowering gene-therapy agent AMT-130, clearing path to human trials in Huntington’s Disease patients
-

Advances on many fronts in the battle against the protein that causes Huntington's disease
⏱️ 11 min read
This fall sees exciting announcements from a number of companies focused on novel Huntingtin Lowering technologies, including Wave, PTC and Voyager
-

HDSA FAQ on the Roche/Genentech RG6042 program
⏱️ 18 min read
HDSA's frequently asked questions factsheet about the huntingtin-lowering trial ASO program was so good we stole it (with permission)
-

Kids sometimes get Huntington’s disease too
⏱️ 6 min read
Finally, a big study that shows what childhood HD looks like. This will help us work out if new drugs work in children too
-

Roche announces details of its 'pivotal' huntingtin-lowering study
⏱️ 10 min read
The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease
-

Disappointing news from LEGATO-HD trial of laquinimod in Huntington's disease
⏱️ 5 min read
The LEGATO-HD trial of laquinimod did not slow progression of Huntington's disease. Here's the lowdown.
-

HDBuzz Enrolls in Enroll-HD
⏱️ 12 min read
As promised, HDBuzz's Jeff Carroll finally signed up for the Enroll-HD study. Learn more about this important global HD "observational study" here.
-

First Dolly, now Piglet; a new Huntington’s disease pig knock-in model confirmed
⏱️ 7 min read
For the first time in HD research, an animal model has been created in pigs using 2 cutting edge DNA editing t
-

New collaboration seeks to speed Huntington's disease drug licensing
⏱️ 6 min read
Critical Path Institute launches new initiative to get HD drugs licensed as quickly as possible
-

HDSA’s Q&A on the latest huntingtin-lowering update from Ionis and Roche
⏱️ 5 min read
Our friends at @hdsa have produced this really good Q&A document about the latest huntingtin-lowering news.
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
